Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

49.23
Delayed Data
As of Jan 20
 -6.26 / -11.28%
Today’s Change
48.92
Today|||52-Week Range
77.12
-15.76%
Year-to-Date
Why Rite Aid, Bristol-Myers Squibb, and TransDigm Group Slumped Today
Jan 20 / MotleyFool.com - Paid Partner Content
AstraZeneca Offers Update on Immuno-Oncology Program
Jan 18 / Zacks.com - Paid Partner Content
Jim Cramer on Bristol Myers' Opdivo/Yervoy Combo: 'That Story Was Taken Away From Us'
Jan 20 / TheStreet.com - Paid Partner Content
Top Research Reports for Microsoft, Biogen & Home Depot
Jan 17 / Zacks.com - Paid Partner Content
Why Bristol-Myers Squibb Co Stock Is Slipping Today
Jan 20 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb May Be a Merger Target Soon
Jan 17 / TheStreet.com - Paid Partner Content
Synergy Pharmaceuticals Consolidating Recent Gains
Jan 20 / TheStreet.com - Paid Partner Content
AstraZeneca expands trials for key cancer drug
Jan 17 / FT.com - Paid Partner Content
Bristol-Myers shares slide on immunotherapy setback
Jan 20 / FT.com - Paid Partner Content
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk
Jan 13 / Zacks.com - Paid Partner Content
Bristol-Myers to Not Seek Accelerated Approval for Opdivo+Yervoy
Jan 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb, Where Art Thou? Not in First-Line Lung Cancer Immunotherapy, Sa...
Jan 20 / TheStreet.com - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Investors await Trump inauguration; Drugs battle; GE earnings
Jan 20 / CNNMoney.com
3 Charts Every Bristol-Myers Squibb Shareholder Needs to See
Jan 11 / MotleyFool.com - Paid Partner Content
Boulegeris Investments, Inc. Buys Nimble Storage Inc, JPMorgan Chase & Co, Bristol-My...
Jan 19 / GuruFocus News - Paid Partner Content
Roche Gets Priority Review for Immunotherapy Drug Tecentriq
Jan 10 / Zacks.com - Paid Partner Content
Oakbrook Investments Llc Buys Visa Inc, Varian Medical Systems Inc, United Technologi...
Jan 19 / GuruFocus News - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
Jan 19 / Zacks.com - Paid Partner Content
2 Top Stocks in Biotech
Jan 09 / MotleyFool.com - Paid Partner Content
Jacobs & Co Buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb Company, Sell...
Jan 18 / GuruFocus News - Paid Partner Content
Here's a Biotech IPO You'll Want to Watch
Jan 09 / MotleyFool.com - Paid Partner Content
Eastern Bank Buys iShares TIPS Bond, Bristol-Myers Squibb Company, iShares Russell Mi...
Jan 18 / GuruFocus News - Paid Partner Content
Trump threat fails to halt drug price hikes in 2017
Jan 04 / CNNMoney.com
The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and B...
Jan 18 / Zacks.com - Paid Partner Content
Corporate moments to look out for in 2017
Dec 30 / FT.com - Paid Partner Content